Papers
61
Total Citations
3,025
H-Index
22
About
Paolo Pietro Bianchi is a pioneering surgical oncologist whose career has been defined by his expertise in minimally invasive and robotic surgery, with a particular focus on colorectal cancer, hepatobiliary procedures, and thoracic oncology. His most influential contribution—a landmark 2017 multicenter randomized controlled trial comparing robotic-assisted versus conventional laparoscopic rectal cancer surgery—has amassed over 1,300 citations, establishing it as a cornerstone reference in modern surgical oncology and directly shaping international clinical practice guidelines. Bianchi has been instrumental in advancing the evidence base for robotic total mesorectal excision, demonstrating its oncological safety and technical advantages over laparoscopy across multiple studies spanning more than a decade. His early comparative analyses of robotic and laparoscopic rectal resection helped legitimize robotic platforms during a critical period of adoption. Beyond colorectal surgery, he has made notable contributions to single-site robotic cholecystectomy, near-infrared fluorescence cholangiography, and robotic pulmonary lobectomy, reflecting an unusually broad surgical scope. More recently, Bianchi has positioned himself at the frontier of next-generation robotic technology, authoring some of the earliest reports on emerging platforms including the Hugo RAS system. His body of work, spanning foundational trials to cutting-edge platform evaluation, underscores a sustained commitment to advancing precision, safety, and innovation in minimally invasive surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8Experience with Robotic Lobectomy for Lung Cancer67 citations · 2011
- 9
- 10